Castlight Health, inc. (CSLT) Stake Lessened by Royce & Associates LP

Royce & Associates LP lowered its stake in shares of Castlight Health, inc. (NYSE:CSLT) by 59.2% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 189,209 shares of the software maker’s stock after selling 274,500 shares during the period. Royce & Associates LP owned 0.14% of Castlight Health, inc. worth $785,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors also recently added to or reduced their stakes in the company. Teachers Advisors LLC increased its position in Castlight Health, inc. by 8.1% in the fourth quarter. Teachers Advisors LLC now owns 62,781 shares of the software maker’s stock worth $311,000 after purchasing an additional 4,717 shares during the last quarter. Acadian Asset Management LLC bought a new stake in Castlight Health, inc. in the first quarter worth $329,000. Oxford Asset Management bought a new stake in Castlight Health, inc. in the first quarter worth $102,000. Stifel Financial Corp increased its position in Castlight Health, inc. by 4.3% in the first quarter. Stifel Financial Corp now owns 36,500 shares of the software maker’s stock worth $133,000 after purchasing an additional 1,500 shares during the last quarter. Finally, FMR LLC increased its position in Castlight Health, inc. by 3.4% in the first quarter. FMR LLC now owns 7,665,919 shares of the software maker’s stock worth $27,980,000 after purchasing an additional 254,804 shares during the last quarter. Hedge funds and other institutional investors own 41.29% of the company’s stock.

Several equities research analysts recently weighed in on the stock. Dougherty & Co restated a “buy” rating on shares of Castlight Health, inc. in a research report on Thursday, August 17th. BidaskClub cut shares of Castlight Health, inc. from a “buy” rating to a “hold” rating in a research report on Monday, July 24th. Chardan Capital assumed coverage on shares of Castlight Health, inc. in a research report on Tuesday, June 6th. They issued a “buy” rating and a $4.50 price target on the stock. Zacks Investment Research upgraded shares of Castlight Health, inc. from a “sell” rating to a “hold” rating in a research report on Tuesday, June 27th. Finally, ValuEngine upgraded shares of Castlight Health, inc. from a “sell” rating to a “hold” rating in a research report on Tuesday, August 1st. Three equities research analysts have rated the stock with a sell rating, five have given a hold rating and two have issued a buy rating to the stock. The stock has a consensus rating of “Hold” and a consensus target price of $4.57.

TRADEMARK VIOLATION WARNING: “Castlight Health, inc. (CSLT) Stake Lessened by Royce & Associates LP” was published by StockNewsTimes and is owned by of StockNewsTimes. If you are accessing this piece on another site, it was illegally copied and republished in violation of U.S. and international trademark & copyright legislation. The correct version of this piece can be read at https://stocknewstimes.com/2017/09/18/castlight-health-inc-cslt-stake-lessened-by-royce-associates-lp.html.

Castlight Health, inc. (NYSE:CSLT) opened at 4.05 on Monday. The firm’s 50-day moving average is $3.99 and its 200-day moving average is $3.89. The company’s market cap is $533.33 million. Castlight Health, inc. has a 52-week low of $3.05 and a 52-week high of $5.50.

Castlight Health, inc. (NYSE:CSLT) last announced its quarterly earnings data on Wednesday, August 2nd. The software maker reported ($0.07) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.09) by $0.02. The company had revenue of $32.10 million for the quarter, compared to analyst estimates of $31.14 million. Castlight Health, inc. had a negative return on equity of 36.30% and a negative net margin of 42.54%. The firm’s revenue for the quarter was up 36.0% on a year-over-year basis. During the same quarter last year, the firm posted ($0.11) EPS. On average, equities research analysts anticipate that Castlight Health, inc. will post ($0.25) EPS for the current year.

In other Castlight Health, inc. news, insider Giovanni M. Colella sold 26,800 shares of the firm’s stock in a transaction on Friday, August 11th. The stock was sold at an average price of $3.89, for a total value of $104,252.00. Following the completion of the sale, the insider now directly owns 78,906 shares of the company’s stock, valued at approximately $306,944.34. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO John C. Doyle sold 35,184 shares of the firm’s stock in a transaction on Thursday, August 17th. The stock was sold at an average price of $3.65, for a total value of $128,421.60. Following the completion of the sale, the chief executive officer now directly owns 75,639 shares of the company’s stock, valued at $276,082.35. The disclosure for this sale can be found here. Insiders sold a total of 208,287 shares of company stock worth $795,240 in the last 90 days. 24.38% of the stock is currently owned by insiders.

Castlight Health, inc. Company Profile

Castlight Health, Inc offers a health benefits platform that engages employees to make healthcare decisions, and enables employers to communicate and measure their benefit programs. The Company operates through cloud-based products segment. Its technology offering aggregates data and applies analytics to make healthcare data transparent.

Institutional Ownership by Quarter for Castlight Health, inc. (NYSE:CSLT)

Receive News & Ratings for Castlight Health inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Castlight Health inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply